A recent report identified that heterozygous germline pLOF MUTYH mutations were observed twice as frequently in The Cancer Genome Atlas prostate adenocarcinoma cohort than in gnomAD cancer–free individuals [41]; however, population stratification between these disparate cohorts cannot be discounted. The gene discussed is MUTYH; the disease is prostate adenocarcinoma.